Sartorius Ag (SARTF) Downgraded to “Sell” at Zacks Investment Research

Sartorius Ag (NASDAQ:SARTF) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday.

According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “

Separately, DZ Bank AG restated a “sell” rating on shares of Sartorius Ag in a research report on Friday, July 21st.

Sartorius Ag (NASDAQ SARTF) traded up 0.0000% on Wednesday, hitting $94.0688. Sartorius Ag has a 52-week low of $75.00 and a 52-week high of $96.00. The company has a market cap of $6.43 billion and a P/E ratio of 52.0004.

TRADEMARK VIOLATION NOTICE: This news story was reported by Markets Daily and is the property of of Markets Daily. If you are accessing this news story on another domain, it was stolen and republished in violation of international copyright and trademark laws. The original version of this news story can be read at https://www.themarketsdaily.com/2017/10/11/sartorius-ag-sartf-downgraded-to-sell-at-zacks-investment-research.html.

Receive News & Ratings for Sartorius Ag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Ag and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply